Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang J; Czerwiec FS; The New England Journal Of Medicine, 2012, vol. 367, issue 25, p 2407, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation